Dupliumab (Dupixent)

There is finally going to be a new, safe and dramatically effective breakthrough treatment for adults with severe atopic dermatitis. Often called eczema, atopic dermatitis is a severe itchy red rash that is associated with other allergic symptoms such as asthma and allergies. Though often mild, severe cases have devastating effects on patients’ lives. Itching and bleeding disrupt daily activities and are uncomfortable and embarrassing. These patients are also at increased risk of dangerous bacterial and viral infections. Dupilumab (brand name Dupixent) is expected to be approved in early 2017 for the treatment of atopic dermatitis in adults ages 18 and up.

As a clinical investigator for Dupixent, Dr. Weisman has had more exposure to the medication than any dermatologist in the Atlanta area. She was a principal investigator for two of the largest Dupixent studies, and she has had an opportunity to see first hand the remarkable effects of this medication. It is truly a life changer for these patients, some of whom have never known a minute of comfort in their own skin. We hope that Dupixent will be the first of many game-changing treatments for eczema. At Medical Dermatology Specialists, we strive to offer the latest and safest ways to treat skin disease, whether with existing or emerging medications. If you have any questions about Dupixent, eczema, atopic dermatitis or other inflammatory skin disease, please contact us today to make an appointment so we can discuss the best way to make you comfortable and healthy. We want you to love the skin you’re in.